US 9161984
Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
granted A61KA61K38/1703A61K38/1709
Quick answer
US patent 9161984 (Formulations and methods of use for alpha connexin C-terminal (ACT) peptides) held by FIRSTSTRING RESEARCH, INC. expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- FIRSTSTRING RESEARCH, INC.
- Grant date
- Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/1703, A61K38/1709, A61K38/1767, A61K38/177